Company profile for Disc medicine

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Disc Medicine is a hematology company harnessing new insights in hepcidin biology to address ineffective red blood cell production (erythropoiesis). Focused on the hepcidin pathway, the master regulator of iron metabolism, Disc is advancing first-in-class therapies to transform the treatment of hematologic disease. Disc Medicine’s therapies are designed to regulate hepcidin expression and treat patients with hematologic dise...
Disc Medicine is a hematology company harnessing new insights in hepcidin biology to address ineffective red blood cell production (erythropoiesis). Focused on the hepcidin pathway, the master regulator of iron metabolism, Disc is advancing first-in-class therapies to transform the treatment of hematologic disease. Disc Medicine’s therapies are designed to regulate hepcidin expression and treat patients with hematologic diseases. Our core development programs target hepcidin biology.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
300 Technology Square, Cambridge, MA 02139
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/11/06/3182593/0/en/Disc-Medicine-Reports-Third-Quarter-2025-Financial-Results-and-Provides-Business-Update.html

GLOBENEWSWIRE
06 Nov 2025

https://www.globenewswire.com/news-release/2025/11/03/3179386/0/en/Disc-Medicine-Announces-Presentation-of-Initial-Data-from-RALLY-MF-Phase-2-Trial-in-Patients-with-Myelofibrosis-MF-and-Anemia-at-the-67th-American-Society-of-Hematology-ASH-Annual-.html

GLOBENEWSWIRE
03 Nov 2025

https://www.globenewswire.com/news-release/2025/10/31/3178303/0/en/Disc-Medicine-to-Participate-in-Upcoming-Investor-Conferences.html

GLOBENEWSWIRE
31 Oct 2025

https://www.globenewswire.com/news-release/2025/10/21/3169903/0/en/Disc-Medicine-Announces-Pricing-of-250-Million-Upsized-Public-Offering-of-Common-Stock-and-Pre-Funded-Warrants.html

GLOBENEWSWIRE
21 Oct 2025

https://www.globenewswire.com/news-release/2025/10/20/3169232/0/en/Disc-Medicine-Announces-Proposed-Public-Offering-of-Common-Stock-and-Pre-Funded-Warrants.html

GLOBENEWSWIRE
20 Oct 2025

https://www.globenewswire.com/news-release/2025/10/20/3169201/0/en/Disc-Medicine-Provides-Update-on-Hematology-Portfolio-and-Outlines-Near-Term-Business-Objectives-and-Anticipated-Milestones.html

GLOBENEWSWIRE
20 Oct 2025

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty